Eckert & Ziegler Equity 2024

Eckert & Ziegler Aktienanalyse

What does Eckert & Ziegler do?

The Eckert & Ziegler Strahlen und Medizintechnik AG is an international company that offers both medical and industrial products and services in the field of radiation application. The company was founded in 1997 and has its headquarters in Berlin. The history of the company began in the 1960s when the two founders, Dr. Andreas Eckert and Dr. Edgar Ziegler, started producing medical isotopes for the diagnosis and therapy of cancer patients. After initially working in a laboratory in Berlin, they founded Eckert & Ziegler Isotope Products GmbH in 1983. In the following years, the company expanded and added radiation sources for industrial applications to its portfolio. In 1997, Eckert & Ziegler Strahlen und Medizintechnik AG was founded to consolidate the two business areas and expand the international business. Today, the company operates worldwide and employs over 800 people. The company's business model focuses on the application of radiation in various industries. The company relies on different business areas that can be divided into medical and industrial applications. In the medical field, Eckert & Ziegler develops and produces radiation sources for the diagnosis and therapy of cancer and other diseases. The products include radioactive isotopes used for the production of medications, the equipment of clinics, and research. Particularly important are radioactive substances for the treatment of prostate cancer, which are highly sought after due to their high effectiveness in patients. In the field of industrial applications, the company offers radiation sources for various industries, such as medical imaging, sterilization of medical devices, or non-destructive testing of materials in the automotive and aviation industries. The company also develops customized solutions for specific customer needs. Another important business area is the disposal of radioactive waste. Here, the company offers solutions for hospitals, research institutions, and companies that work with radioactive substances and must comply with legal requirements for disposal. Eckert & Ziegler is a company that focuses on innovation and research. The company continuously invests in research and development to keep its products and services up to date. For this purpose, the company maintains close relationships with research institutions and universities to develop new technologies and products. The company also strives to make its products and services environmentally friendly and sustainable. It relies on the use of renewable energies, energy efficiency, and recyclability of products. Overall, Eckert & Ziegler Strahlen und Medizintechnik AG is a leading company in the application of radiation in medical and industrial applications. The company relies on innovative products and solutions to meet the needs of its customers. Eckert & Ziegler ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Eckert & Ziegler's Equity

Eckert & Ziegler's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Eckert & Ziegler's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Eckert & Ziegler's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Eckert & Ziegler's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Eckert & Ziegler’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Eckert & Ziegler stock

What is the equity of Eckert & Ziegler this year?

Eckert & Ziegler has equity of 222.18 M EUR this year.

What was the equity of Eckert & Ziegler compared to the previous year?

The equity of Eckert & Ziegler has increased/decreased by 4.77% increased compared to the previous year.

What impact does a high equity have on investors of Eckert & Ziegler?

A high equity is advantageous for investors of Eckert & Ziegler as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Eckert & Ziegler?

A low equity can be a risk for investors of Eckert & Ziegler, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Eckert & Ziegler affect the company?

An increase in equity of Eckert & Ziegler can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Eckert & Ziegler affect the company?

A reduction in equity of Eckert & Ziegler can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Eckert & Ziegler?

Some factors that can affect the equity of Eckert & Ziegler include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Eckert & Ziegler so important for investors?

The equity of Eckert & Ziegler is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Eckert & Ziegler take to change the equity?

To change equity, Eckert & Ziegler can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Eckert & Ziegler pay?

Over the past 12 months, Eckert & Ziegler paid a dividend of 0.5 EUR . This corresponds to a dividend yield of about 1.12 %. For the coming 12 months, Eckert & Ziegler is expected to pay a dividend of 0.55 EUR.

What is the dividend yield of Eckert & Ziegler?

The current dividend yield of Eckert & Ziegler is 1.12 %.

When does Eckert & Ziegler pay dividends?

Eckert & Ziegler pays a quarterly dividend. This is distributed in the months of July, July, June, July.

How secure is the dividend of Eckert & Ziegler?

Eckert & Ziegler paid dividends every year for the past 23 years.

What is the dividend of Eckert & Ziegler?

For the upcoming 12 months, dividends amounting to 0.55 EUR are expected. This corresponds to a dividend yield of 1.22 %.

In which sector is Eckert & Ziegler located?

Eckert & Ziegler is assigned to the 'Health' sector.

Wann musste ich die Aktien von Eckert & Ziegler kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Eckert & Ziegler from 7/1/2024 amounting to 0.05 EUR, you needed to have the stock in your portfolio before the ex-date on 6/27/2024.

When did Eckert & Ziegler pay the last dividend?

The last dividend was paid out on 7/1/2024.

What was the dividend of Eckert & Ziegler in the year 2023?

In the year 2023, Eckert & Ziegler distributed 0.5 EUR as dividends.

In which currency does Eckert & Ziegler pay out the dividend?

The dividends of Eckert & Ziegler are distributed in EUR.